Call for proposals for research funding for young researchers through the Centre for Advanced Study (CAS). Check the link below and see if this is of interest to you. The deadline is Dec. 9.
https://cas-nor.no/young-cas-grant
Call for proposals for research funding for young researchers through the Centre for Advanced Study (CAS). Check the link below and see if this is of interest to you. The deadline is Dec. 9.
https://cas-nor.no/young-cas-grant
We are happy to invite you all to the CCBIO Junior Scientist Symposium, December 6, 2023. This seminar series is a perfect place to meet and interact with other young scientists. We anticipate lively and interesting discussion also this time. We are looking forward to the keynote lecture by CCBIO Professor Dana Costea, who will share her story about how and why she ended up in cancer research. The program spans several exiting topics including preclinical development of new therapeutics in mantle cell lymphoma, the link between salivary gland manifestation and renal disease in Sjøgren’s Syndrome and how brain-blood derived exosomes may act as biomarkers in multiple sclerosis (MS). A novel tool for spatial analyses of the tumor microenvironment will also be presented.
Please register within December 4th at 11.00.
When: December 6, 2023, at 09.00-13.00
Where: Auditorium B302, Sentralblokka, Haukeland University Hospital 3rd floor, Bergen
Registration: on this link
Open to both junior and senior researchers as well as students. The symposium series is open, but also part of the CCBIO Research School under the code CCBIO901, and participation is eligible for ECTS.
Program:
09.00-09.15: Introduction
09.15-10.00: “My Path in the World of Cancer Research” Keynote lecture by Professor Daniela Costea
10.00-10.20: Coffee break
10.20-10.45: “Preclinical development of novel therapeutics in Mantle Cell Lymphoma” by May Eriksen Gjerstad
10.45-11.10: “Sjögren’s syndrome- Assessment of salivary gland manifestations and their association with renal disease” by Hanne Borge
11.10-12:00 Lunch (free of charge, register within December 4th at 11.00)
12:00-12:25: “Brain-derived blood exosomes – a potential for new biomarkers in multiple sclerosis: Pilot study results from relapsing MS patients under anti-CD20 therapy” by Sam Anandhan
12:25-12:50: “Spatial analysis of the cancer tissue microenvironment using mass cytometry imaging technologies” Rezvan Ehsani
12:50-13:00: Concluding remarks
Mari Kyllesø Halle and Vladan Milosevic are coordinators of the junior seminars and are planning and chairing these meetings. Any questions can be addressed to them.
In UiB’s application portal, an overview is provided of various foundations from which it is possible to apply for funds. These foundations have research and education at the University of Bergen as their statutory purposes.
The target audience includes employees, doctoral candidates, postdoctoral researchers, and students at UiB. Some of the foundations also allow external individuals to apply for funds. Information about who can apply can be found by examining each foundation in the portal.
In the application portal, it is also possible to filter based on the applicant group (employee, student, doctoral candidate, etc.) and/or the field of study to which one belongs, and relevant foundations will be displayed.
The general application deadline is January 12, 2024.
Note that the Astri and Edvard Riisøens legacy is not yet included in the application portal but will be added soon. The legacy provides funding for research on cardiovascular diseases and other unexplored diseases, such as cancer and rheumatic disorders.
Also, please refer to the faculty’s website (in Norwegian) that deals with funds and legacies. This page will be updated if funds are announced from foundations not included in UiB’s application portal.
This is an excellent opportunity for curiosity-driven, talented researchers from all over the world and within all research disciplines
Up to 10 fellowships are available for curiosity-driven, talented researchers from all over the world and within all research disciplines. The new AIAS-AUFF Fellowships have a duration of 23 months, starting on 1 September 2024.
As a fellow you will benefit from the international and multidisciplinary environment at AIAS that brings researchers together across disciplines, academic seniority and borders in a thriving and creative house.
Eligibility
https://aias.au.dk/events/show/artikel/10-individual-fellowships-open-for-application
Cancer researchers can apply for project funding from Foundation Dam/Stiftelsen Dam. In addition to researcher positions, support for research in line with the purpose of the program can be applied for.
The application is sent to the Norwegian Cancer Society, which mediates applications for funds to Foundation Dam.
The application deadline for sketches is Thursday 1st of February 2024.
We look forward to receiving your application!
Read more in Norwegian https://dam.no/programmer/forskning/utlysning/
Apply for funding in Norwegian https://kreftforeningen.no/forskning/sok-forskningsmidler/#h-utlysninger
Are you passionate about AI, healthcare, or both? Do you aspire to understand how data can revolutionize the healthcare industry? Would you like to work closely with leading medical AI experts and clinicians from around the world? |
At this event, clinicians, data scientists, and social scientists will come together to harness clinical data and apply machine learning to address specific healthcare challenges. This year, alongside advancing AI in medicine, we will place a special emphasis on addressing biases in health data. Event Details: 📆 Date: January 7-8, 2024 (with a pre-meeting online on January 5). 📍 Location: Eitri Medical Incubator, Haukelandsbakken 31, Bergen For more information and to register, visit: https://www.eitrilab.no/datathon2024 Don’t miss this opportunity to be part of a transformative healthcare journey! For inquiries, please, email Torleif at tml@visinnovasjon.no or Maija at maija.slaidina@uib.no. |
|
Help build medical research in Western Norway
On Tuesday this week, a joint research day was organized between the Faculty of Medicine and Stavanger University Hospital. Many projects were presented illustrating what we can achieve together.The papers presented by a representative from each campus emphasized the utility of registries and the strength of large patient cohorts. Including both Bergen and Stavanger in a study means that the number of participants can be doubled, which can be the difference between a mediocre study and excellent study as it is easier to obtain statistically significant findings. Camilla Krakstad also highlighted the opportunities that lie in a research stay abroad and how good registers and biobanks make us attractive collaborators. The K2 management is now actively working to improve collaborations between Stavanger and Bergen and encourage colleagues to build research groups together. Many of the groups in Bergen are larger than in Stavanger and it can therefore be a good idea to include colleagues in the groups where it is natural to collaborate. How this is solved in practical terms is up to each group, but joint research meetings digitally and physically are a good place to start. To invite each other to university tasks such as committee work is a way to facilitate interactions. Building joint projects should strengthen competitiveness when applying for research grants. There are also good synergies to be gained on the teaching side, where we should collaborate more, coordinate teaching plans, share teaching materials and exams. If subjects and exams come at the same time, we can use the same assignments. In other words, there are many possibilities to collaborate here. The next time we organize such a meeting, it would also be good if those who do not have ongoing collaborative projects between our campuses to participate, it could pay off.
Have a good weekend when time comes,
Eystein Husebye
Vice Head of Department
We publish draft information on future call topics a few months ahead of the official call launch. We do this to give you additional time to find or build a consortium and prepare a strong proposal. Note that as draft topics are still under development, the texts may change considerably between the versions published here and the call launch, and you should always check the final, approved topic texts once the calls are launched.
The following topics are under consideration for inclusion in IHI call 6 (two-stage) and IHI call 7 (single-stage):
The topics are currently under consultation with the States’ Representatives Group (SRG) and the Science and Innovation Panel (SIP). They may therefore change considerably between the versions published here and the call launch, and applicants should check the final, approved topic texts once the calls are launched.
https://www.ihi.europa.eu/apply-funding/future-opportunities